Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

(2016)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens

(2013) Nicholas L. Smith et al.   JAMA Internal Medicine

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives

(2012) M. RAPS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A decade of postmenopausal hormone therapy prescribing in the United States

(2012) Amy R. Steinkellner et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Increased thrombin generation among postmenopausal women using hormone therapy

(2011) Pierre-Yves Scarabin et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy

(2010) C. N. BAGOT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Mechanisms of Estrogen-Induced Venous Thromboembolism

(2010) Svetlana N. Tchaikovski et al.   THROMBOSIS RESEARCH

Antihypertensive Treatment With ACE Inhibitors or  -Blockers and Risk of Incident Atrial Fibrillation in a General Hypertensive Population

(2009) S. R. Heckbert et al.   AMERICAN JOURNAL OF HYPERTENSION

Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study

(2009) P. L. LUTSEY et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study

(2008) M. BESSER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS